TOKYO — Drugmaker Daiichi Sankyo is building the first factory in Japan for a homegrown mRNA vaccine against COVID-19, with a planned capac
This content was originally published here.
TOKYO — Drugmaker Daiichi Sankyo is building the first factory in Japan for a homegrown mRNA vaccine against COVID-19, with a planned capac
This content was originally published here.